CAPR Stock Skyrockets 282% in a Week: Here's What You Need to KnowZacks Investment Research • 12/05/25
Capricor Skyrockets 535% After Getting Vindication In Muscular DystrophyInvestors Business Daily • 12/03/25
Capricor Therapeutics Duchenne Treatment Shows Strong Heart And Muscle Results In TrialBenzinga • 12/03/25
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law FirmGlobeNewsWire • 11/10/25
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, DeramiocelGlobeNewsWire • 11/03/25
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10GlobeNewsWire • 10/31/25
CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 10/08/25
Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing InvestigationGlobeNewsWire • 10/03/25
Capricor Therapeutics: A Buy Ahead Of Phase 3 Topline And Clarified Regulatory PathwaySeeking Alpha • 09/29/25
Capricor (CAPR) Surges 5.3%: Is This an Indication of Further Gains?Zacks Investment Research • 09/26/25
Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A MeetingGlobeNewsWire • 09/25/25
CAPRICOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 09/16/25
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPRBusiness Wire • 09/15/25
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPRPRNewsWire • 09/15/25
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmPRNewsWire • 09/15/25
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • 09/14/25